Reaction

Laryngospasm reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,659 reports · 46 co-occurring drugs

As of the last recalculation, Laryngospasm appears in 2,659 FAERS reports alongside 46 co-occurring drug terms. The strongest observed disproportionality signal is SEVOFLURANE (PRR 65.7).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Sevoflurane	68	65.7	66.2
Oxaliplatin	392	48.3	48.6
Propofol	165	37.6	37.8
Rocuronium Bromide	52	35.2	35.4
Atropine	28	26.7	26.8
Atropine Sulfate	33	24.2	24.3
Capecitabine	174	15.9	15.9
Midazolam Hydrochloride	45	13.3	13.3
Midazolam	40	12.6	12.6
Fluorouracil Cream, 0.5%	116	12.4	12.4
Fluorouracil	116	12.2	12.2
Magnesium Sulfate In Water For	18	11.1	11.1
Magnesium Sulfate Heptahydrate	18	10.9	10.9
Magnesium Sulfate	18	10.9	10.9
Granisetron Hydrochloride	14	10.5	10.6
Leucovorin Calcium	23	9.5	9.5
Dexamethasone Sodium Phosphate	12	9.3	9.3
Fentanyl	111	9.2	9.2
Granisetron	12	9.0	9.0
Iohexol	8	7.6	7.6
Ciclesonide	13	7.5	7.5
Irinotecan Hydrochloride	12	7.3	7.3
Ondansetron Hydrochloride	107	7.1	7.1
Fentanyl Citrate	16	7.0	7.1
Panitumumab	14	7.0	7.0
Cefazolin	8	6.9	6.9
Ondansetron	91	6.7	6.7
Ondansetron Tablets	91	6.7	6.7
Paclitaxel (Aibumin-Bound)	67	6.5	6.5
Fosaprepitant Dimeglumine	11	6.3	6.3
Gemcitabine	30	6.0	6.0
Cefazolin Sodium	9	5.9	5.9
Paclitaxel	67	5.4	5.4
Gemcitabine Hydrochloride	36	5.4	5.4
Omalizumab	56	5.2	5.2
Naproxen Sodium Tablet, Coated	9	5.2	5.2
Naproxen Sodium, Coated Tablets	9	5.2	5.2
Naproxen Sodium 220Mg	9	5.2	5.2
Bupivacaine	6	5.0	5.0
Loratadine Oral	31	5.0	5.0
Ziprasidone Mesylate	7	3.9	3.9
Bevacizumab	59	3.8	3.8
Carboplatin	57	3.6	3.6
Botulinum Toxin Type A	5	3.2	3.2
Asenapine Maleate	3	2.7	2.7
Salicylic Acid	3	0.4	0.4

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.